Resilient Drug Supply Project

About the Resilient Drug Supply Project

The Resilient Drug Supply Project focuses on the supply chains and global disruptions for the most critical drugs for life-saving and life-sustaining treatment (funded by a gift from the Walton Family Foundation). Outcomes of this research will improve the healthcare supply system’s ability to maintain a steady and adequate supply of critical medicines and supplies worldwide. 

Learn more

RDSP's Critical Drug Shortage Lists

Stay up to date on the latest shortages on the 40 critical COVID-19 drug list and the 156 critical acute drugs list.

COVID-19: The CIDRAP Viewpoint: Ensuring a resilient US drug supply

RDSP Resources

Learn how COVID-19 exacerbated the US drug shortage problem in "Ensuring a Resilient US Drug Supply," part 6 of CIDRAP's "Viewpoint" series. In it, RDSP has 9 recommendations to change the system from "fail and fix" to "predict and prevent."


Tocilizumab in syringe

Analysis spotlights shortage of a COVID-19 drug in Canada

Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.

Child gets vaccine in Africa

Global groups draw up plan to boost routine immunizations amid COVID-19

Vaccines are just one of many COVID-disrupted services, a recent survey notes.

Luvox (fluvoxamine) packages and pills

OCD drug spotlighted as potential COVID-19 treatment

Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.

Daily allotment of prescription drugs

Some patients halted drugs for chronic conditions during pandemic

In spite of an increase in days of supply, data still show discontinuation of some drugs.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Grant support for RDS provided by

Unrestricted financial support provided by

Bentson Foundation